Back to Search
Start Over
Improved resolution and sensitivity of [18F]MFBG PET compared with [123I]MIBG SPECT in a patient with a norepinephrine transporter–expressing tumour.
- Source :
- European Journal of Nuclear Medicine & Molecular Imaging; 2021, Vol. 48 Issue 1, p313-315, 3p, 1 Color Photograph
- Publication Year :
- 2021
-
Abstract
- Improved resolution and sensitivity of [18F]MFBG PET compared with [123I]MIBG SPECT in a patient with a norepinephrine transporter-expressing tumour Moreover, if neural crest tumour patients are considered for peptide receptor radionuclide therapy, addition of norepinephrine transporter imaging to the pre-therapeutic work-up allows evaluating whether [ SP 131 sp I]MIBG or a combination treatment may increase therapeutic efficacy. [ SP 18 sp F]MFBG is a promising clinical PET alternative for [ SP 123 sp I]MIBG, offering improved sensitivity, same-day imaging and the possibility of PET/MR imaging, as a one-stop-shop for patients with norepinephrine transporter-expressing tumours. [Extracted from the article]
Details
- Language :
- English
- ISSN :
- 16197070
- Volume :
- 48
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- European Journal of Nuclear Medicine & Molecular Imaging
- Publication Type :
- Academic Journal
- Accession number :
- 148321529
- Full Text :
- https://doi.org/10.1007/s00259-020-04830-x